Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

4results about How to "High transduction efficiency" patented technology

Bispecific antibodies targeting cd22 and cd19 and chimeric antigen receptors and uses thereof

ActiveCN116217732BHigh transduction efficiencyincrease lethalitySingle-Chain AntibodiesTumor antigen
The application belongs to the technical field of cell engineering, and particularly relates to a bispecific antibody targeting CD22 and CD19, a chimeric antigen receptor thereof and application. In the bispecific antibody, a CD22 light chain and a CD22 heavy chain are connected through a linker 4 to form a CD22 single-chain antibody, and a CD19 light chain and a CD19 heavy chain are connected through a linker 4 to form a CD19 single-chain antibody, which comprises one of the following structures: (1) the CD22 single-chain antibody and the CD19 single-chain antibody are connected through a linker 1 or a liner 2; (2) the two ends of the CD19 single-chain antibody are connected with the CD22 light chain and the CD22 heavy chain through a linker 3, respectively. The chimeric antigen receptor provided by the application can simultaneously target two different tumor antigens, improve the killing of tumor cells, reduce the probability of immune escape, and reduce the tumor recurrence rate after CAR-T treatment.
Owner:CHONGQING PRECISION BIOTECH CO LTD +1

Nucleic acid molecules encoding modified retroviral gag proteins and uses thereof

PendingCN122278889AIncrease productionhigh titerInitiating MethionineRetrovirus
This invention discloses a nucleic acid molecule encoding a modified retroviral Gag protein and its applications. The Gag protein contains an engineered acylated tag sequence at its N-terminus, comprising: a glycine residue at the second position after the initiating methionine for myristylation modification; and / or a cysteine ​​residue in the N-terminal region for palmitoylation modification. The tag sequence is selected from SEQ ID NO:1, 3-9, or derivative amino acid sequences having at least 80% identity and retaining function. Preferably, the modification involves replacing the first 9 amino acids at the N-terminus of the wild-type HIV-1 Gag protein with the aforementioned tag to enhance membrane anchoring and improve viral packaging efficiency. This invention also provides packaging plasmids containing this molecule, host cells, packaging systems, and preparation methods. This invention can significantly improve viral yield and titer, and is particularly suitable for overcoming the efficiency bottleneck in packaging large-load lentiviruses of 7-10 kb.
Owner:TSINGHUA UNIVERSITY

Truncated transposase, transposome system and applications thereof

The application provides a truncated transposase, a transposon system and application thereof. Compared with a wild-type PS transposase, the truncated transposase lacks 1-50 amino acids at the C terminal of the wild-type PS transposase, preferably 44 amino acids. By deleting the amino acids at the C terminal of the transposase which have less influence on transposition, the length of the transposase is shortened, which is beneficial to the expression of the transposase and the preparation of a fusion protein, so that a transposase or a fusion protein thereof with higher catalytic activity and smaller size is obtained. The application also provides a fusion protein of the transposase, which is preferably fused with a leucine zipper through a linker, and a transposon system comprising the transposase and the transposon, which has great application value in the transgenic industry.
Owner:MAXIRNA (SHANGHAI) PHARM CO LTD +2

A method for preparing a wearable potentiometric ion sensor based on conductive polymer nanofiber membranes

The application relates to a method for preparing a wearable potential ion sensor based on a conductive polymer nanofiber membrane and belongs to the field of electrochemical sensing. The method mainly comprises the following steps: (1) conductive polymer monomer solution and initiator-crosslinking agent mixed solution are successively drop-coated on the surface of an electrode, the latter induces monomer assembly polymerization, a conductive polymer nanofiber membrane is obtained, and drying is performed; (2) an ion-selective membrane dispersion liquid is prepared according to a certain proportion and is dropwise added to the electrode, and film drying is performed; (3) after the prepared electrode is dried overnight in the dark, the electrode is placed in a prepared standard ion solution (to-be-measured ion) for pretreatment; and (4) the electrode is placed in ion solutions with different concentrations for testing, the relationship between ion concentration and voltage is obtained, a standard curve and a linear equation are obtained, and monitoring of ion concentration in sweat is realized. The wearable potential ion sensor prepared by the method can realize high-sensitivity real-time monitoring of ions in sweat.
Owner:BEIJING UNIV OF TECH